Mycobacterium chelonae Wound Infections after Plastic Surgery Employing Contaminated Gentian Violet Skin-Marking Solution

New England Journal of Medicine

Volumn 317, Issue 4, 1987, Pages 197-201

  Safranek, Thomas J ^a   Jarvis, William R ^a   Carson, Loretta A ^a   Cusick, Lucy B ^a   Bland, Lee A ^a   Swenson, Jana M ^a   Silcox, Vella A ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFADROXIL; CEFALOTIN; CRYSTAL VIOLET; METHYLPREDNISOLONE;

BREAST; BREAST AUGMENTATION; BREAST RECONSTRUCTION; CLINICAL ARTICLE; DIAGNOSIS; DRUG ANALYSIS; DRUG DETERMINATION; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG RESISTANCE; DRUG SENSITIVITY; EPIDEMIOLOGY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PREVENTION; PRIORITY JOURNAL; RHYTIDOPLASTY; THERAPY; TOPICAL DRUG ADMINISTRATION; WOUND INFECTION;

EID: 0023221195     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198707233170403     Document Type: Article

References (21)

1. American Society of Plastic and Reconstructive Surgeons. Media survey. 1984. (press release, May 16, 1985.)
2. Kamer FM, Damiani J, Churukian M. 512 Rhytidectomies: a retrospective study. Arch Otolaryngol 1984; 110: 368–70.
3. Perras C. The prevention and treatment of infections following breast implants. Plast Reconstr Surg 1965; 35: 649–56.
4. de Cholnoky T. Augmentation mammaplasty: survey of complications in 10,941 patients by 265 surgeons. Plast Reconstr Surg 1970; 45: 573–7.
5. Cronin TD, Greenberg RL. Our experiences with the silastic gel breast prosthesis. Plast Reconstr Surg 1970; 46: 1–7.
6. Courtiss EH, Goldwyn RM, Anastasi GW. The fate of breast implants with infections around them. Plast Reconstr Surg 1979; 63: 812–6.
7. Toranto IR, Malow JB. Atypical mycobacteria periprosthetic infections — diagnosis and treatment. Plast Reconstr Surg 1980; 66: 226–8.
8. Clegg HW, Foster MT, Sanders WE Jr, Baine WB. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis 1983; 147: 427–33.
9. Clegg HW, Bertagnoll P, Hightower AW, Baine WB. Mammaplasty-associated mycobacterial infection: a survey of plastic surgeons. Plast Reconstr Surg 1983; 72: 165–9.
10. Continued experience with mycobacteria. Bull Int Soc Clin Plast Surg 1985; 9: 6.
11. Bolan G, Reingold AL, Carson LA, et al. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis 1985; 152: 1013–9.
12. Silcox VA, Good RC, Floyd MM. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol 1981; 14: 686–91.
13. Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium foriuilum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985; 28: 807–11.
14. Carson LA, Petersen NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol 1978; 36: 839–46.
15. Carson LA, Aguero SM, Safranek TJ, Jarvis WR. Growth characteristics of Mycobacterium chelonei in aqueous gentian violet solutions. In: Hartman PA, Smith PF, Schlessinger D, et al., eds. Abstracts of the annual meeting of the American Society for Microbiology. 1987. Washington, D.C.: American Society for Microbiology, 1987:406. abstract.
16. Churchman JW. The selective bactericidal action of gentian violet. J Exp Med 1912; 16: 221–47.
17. Reynolds JEF, ed. Martindale: the extra pharmacopoeia. 28th ed. London: Pharmaceutical Press, 1982:560.
18. Asscher AW, Chant ADB, Marshall R. Improved skin-marking. Lancet 1968; 2: 638.
19. Band JD, Ward JI. Fraser DW, et al. Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 1982; 145: 9–17.
20. Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ. Sternal wound infections and endocarditis due to organisms of the Mycobacterium foriuitum complex. Ann Intern Med 1983; 98: 938–9.
21. Goslee S, Wolinsky E. Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis 1976; 113: 287–92.